Replies to post #2814 on CardioVascular BioTherapeutics (fka CVBT)

[GoneforDays]

Like Slalom, I can share some excellent news with you.

"Venturis lost a long legal case resulting in a 7-figure adverse judgement in binding arbitration. Unless some third parties step up and invest, this insolvent, illiquid, zombie company is either going to be liquidated or will declare bankruptcy to temporarily halt the liquidation."

1. VT's affiliate has a $2m+ judgement against the Blubberman aka Daniel C. Montano. This is significantly more that the arbitrator's award (which I believe VT is appealing the award in any event). So Blubberman Montano will get ZILCH.

2. Even if the arbitrator's decision stands he stated that VT could pay when it fitted with it's cash flow and after all clinical trial costs and normal day to day expenditures.